WP_INTEGRATED_CANCER_PATHWAY | Return to index | ||||||||
Order | Gene | Description | ref_hepatocyte | HepG2 | HepG2.C3A | HuH.7 | SNU475 | THLE | liver |
1 | CDKN1A | Cyclin-dependent kinase inhibitor 1 | [1] | 0.20[2] | -1.46[3] | -3.70[4] | -2.61[5] | -0.28[6] | -2.04[7] |
2 | AKT1 | RAC-alpha serine/threonine-protein kinase | [8] | -0.56[9] | -1.07[10] | -1.69[11] | -0.67[12] | -0.88[13] | -0.45[14] |
3 | MYC | Myc proto-oncogene protein | [15] | -0.21[16] | -0.82[17] | -2.40[18] | -3.41[19] | -1.27[20] | -2.20[21] |
4 | BAX | Apoptosis regulator BAX | [22] | -0.31[23] | -1.38[24] | -1.39[25] | -2.22[26] | -2.06[27] | -4.16[28] |
5 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | [29] | -0.71[30] | -1.91[31] | -0.35[32] | 1.91[33] | -0.58[34] | 0.75[35] |
6 | CDK4 | Cyclin-dependent kinase 4 | [36] | 0.69[37] | 1.00[38] | 1.08[39] | -0.44[40] | -0.02[41] | -1.04[42] |
7 | BAD | Bcl2-associated agonist of cell death | [43] | -2.31[44] | -2.45[45] | -2.95[46] | -1.69[47] | -1.51[48] | -1.63[49] |
8 | JAK1 | Tyrosine-protein kinase JAK1 | [50] | -0.13[51] | -0.92[52] | -0.28[53] | 0.01[54] | 0.42[55] | 1.33[56] |
9 | CDKN1B | Cyclin-dependent kinase inhibitor 1B | [57] | -0.72[58] | -0.56[59] | 0.09[60] | -1.73[61] | -1.49[62] | -1.11[63] |
10 | CASP3 | Caspase-3 | [64] | -0.50[65] | -0.10[66] | -2.20[67] | -1.52[68] | -0.75[69] | -1.01[70] |
11 | CDK2 | Cyclin-dependent kinase 2 | [71] | -1.05[72] | -1.16[73] | -0.33[74] | -0.64[75] | -0.28[76] | -2.39[77] |
12 | MSH6 | DNA mismatch repair protein Msh6 | [78] | -0.33[79] | -0.11[80] | 0.55[81] | 0.28[82] | 0.47[83] | 0.09[84] |
13 | MMP1 | Interstitial collagenase | [85] | -5.80[86] | -9.85[87] | [88] | -2.37[89] | -3.05[90] | -12.33[91] |
14 | CASP8 | Caspase-8 | [92] | -0.62[93] | -0.32[94] | -0.70[95] | -0.70[96] | -1.67[97] | -1.62[98] |
15 | PTEN | Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protei | -1.18[99] | -0.06[100] | 0.59[101] | -1.19[102] | -0.16[103] | 2.27[104] | |
16 | MDM2 | E3 ubiquitin-protein ligase Mdm2 | [105] | 1.47[106] | 2.62[107] | 0.30[108] | -0.11[109] | 0.54[110] | 1.96[111] |
17 | SMAD3 | Mothers against decapentaplegic homolog 3 | [112] | 1.29[113] | 0.41[114] | 1.09[115] | 1.18[116] | 1.83[117] | 0.01[118] |
18 | CDK1 | Cyclin-dependent kinase 1 | [119] | 0.61[120] | 2.40[121] | 1.59[122] | 1.65[123] | 2.24[124] | -2.67[125] |
19 | CHEK2 | Serine/threonine-protein kinase Chk2 | [126] | -0.54[127] | -0.37[128] | 0.48[129] | -0.87[130] | -1.47[131] | -3.48[132] |
20 | TP53 | Cellular tumor antigen p53 | [133] | 1.00[134] | 0.29[135] | 1.50[136] | 0.67[137] | 0.11[138] | -0.25[139] |
21 | PLK1 | Serine/threonine-protein kinase PLK1 | [140] | 1.85[141] | 1.32[142] | 1.63[143] | 0.62[144] | 1.44[145] | -2.84[146] |
22 | ATF1 | Cyclic AMP-dependent transcription factor ATF-1 | [147] | -1.26[148] | -0.28[149] | -0.11[150] | -0.47[151] | -0.81[152] | -0.68[153] |
23 | BBC3 | Bcl-2-binding component 3 | [154] | 0.10[155] | -0.29[156] | -0.34[157] | -3.42[158] | -2.89[159] | -4.54[160] |
24 | MSH2 | DNA mismatch repair protein Msh2 | [161] | 0.18[162] | 1.20[163] | 1.09[164] | 1.51[165] | 0.65[166] | -0.90[167] |
25 | RAD50 | DNA repair protein RAD50 | [168] | -0.49[169] | 1.37[170] | 0.97[171] | 0.64[172] | 0.91[173] | 2.00[174] |
26 | CDC25B | M-phase inducer phosphatase 2 | [175] | 1.23[176] | 1.13[177] | 0.96[178] | 2.10[179] | 2.04[180] | 0.14[181] |
27 | BACH1 | Transcription regulator protein BACH1 | [182] | 0.41[183] | 0.46[184] | 1.36[185] | 1.50[186] | 0.51[187] | 2.42[188] |
28 | RB1 | Retinoblastoma-associated protein | [189] | 0.58[190] | 0.80[191] | 1.82[192] | 1.65[193] | 1.75[194] | 1.27[195] |
29 | CASP9 | Caspase-9 | [196] | -0.48[197] | 0.20[198] | -0.23[199] | -0.38[200] | -1.29[201] | -0.74[202] |
30 | SMAD2 | Mothers against decapentaplegic homolog 2 | [203] | 1.38[204] | 1.37[205] | 1.32[206] | 1.76[207] | 1.73[208] | 2.36[209] |
31 | E2F1 | Transcription factor E2F1 | [210] | 1.31[211] | 0.89[212] | 1.47[213] | 1.24[214] | 1.46[215] | -3.82[216] |
32 | CHEK1 | Serine/threonine-protein kinase Chk1 | [217] | 0.90[218] | 0.98[219] | 1.00[220] | 1.53[221] | 1.53[222] | -2.23[223] |
33 | CDKN2B | Cyclin-dependent kinase 4 inhibitor B | [224] | -0.27[225] | -5.02[226] | -0.71[227] | 0.54[228] | 0.62[229] | -2.29[230] |
34 | CDC25A | M-phase inducer phosphatase 1 | [231] | 0.79[232] | 1.15[233] | 1.95[234] | -0.28[235] | 0.95[236] | -2.86[237] |
35 | NOXA1 | NADPH oxidase activator 1 | [238] | -3.00[239] | -1.51[240] | -2.10[241] | -3.01[242] | -4.45[243] | -1.18[244] |
36 | BRCA1 | Breast cancer type 1 susceptibility protein | [245] | 1.03[246] | 2.00[247] | 2.85[248] | 1.52[249] | 1.82[250] | 1.47[251] |
37 | ATR | Serine/threonine-protein kinase ATR | [252] | 0.45[253] | 1.18[254] | 1.71[255] | 1.91[256] | 1.65[257] | 3.34[258] |
38 | MAP3K5 | Mitogen-activated protein kinase kinase kinase 5 | [259] | -4.94[260] | -8.14[261] | -1.80[262] | -2.49[263] | 1.69[264] | 2.85[265] |
39 | ATM | Serine-protein kinase ATM | [266] | 2.39[267] | 3.72[268] | 3.90[269] | 3.53[270] | 2.79[271] | 4.78[272] |
40 | POU2F1 | POU domain, class 2, transcription factor 1 | [273] | 2.46[274] | 2.99[275] | 4.17[276] | 3.50[277] | 2.34[278] | 3.91[279] |
41 | BLM | Bloom syndrome protein | [280] | 0.90[281] | 1.98[282] | 3.24[283] | 2.27[284] | 2.13[285] | -0.59[286] |
42 | BARD1 | BRCA1-associated RING domain protein 1 | [287] | 0.67[288] | 1.39[289] | 1.86[290] | 2.07[291] | 1.93[292] | 1.66[293] |
43 | BCL2 | Apoptosis regulator Bcl-2 | [294] | -3.49[295] | 1.64[296] | -5.32[297] | 1.15[298] | 0.64[299] | 3.03[300] |
44 | MRE11 | Double-strand break repair protein MRE11 | [301] | [302] | [303] | [304] | [305] | [306] | [307] |
45 | MIR3191 | [308] | [309] | [310] | [311] | [312] | [313] | [314] |